申请人:Ishibuchi Seigo
公开号:US08354401B2
公开(公告)日:2013-01-15
Provided are a novel low-molecular-weight compound that suppresses production of induction type MMPs, particularly MMP-9, rather than production of hemostatic type MMP-2, as well as a prophylactic/therapeutic drug for autoimmune diseases or osteoarthritis. An amide derivative represented by the following formula (I)
wherein each symbol is as defined in the specification, a pharmacologically acceptable salt thereof, or a hydrate or solvate thereof.
提供了一种新型低分子量化合物,可以抑制诱导型MMPs(尤其是MMP-9)的产生,而不是止血型MMP-2的产生,以及一种自身免疫疾病或骨关节炎的预防/治疗药物。该化合物是下式(I)所表示的酰胺衍生物,其中每个符号如规范所定义,其药理学上可接受的盐,或其水合物或溶剂化物。